EICHORCondition: Iodine Deficiency · Sponsor: EUthyroid
Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.
In EUthyroid2 intervention measures are to be developed, implemented in ambulatory care settings and evaluated to effectively raise awareness for the risks of iodine deficiency among young women (18-24 years) in three European countries (Norway, Poland, UK) as well as Bangladesh and Pakistan. A cluster-randomized controlled trial with three points of measurements will be applied in each participating country. The intervention will be adapted to the different contextual characteristics of the implementation sites. A process evaluation with a convergent parallel mixed methods design will be conducted. For this, participants and healthcare professionals will be surveyed and semi-structured interviews will be carried out.
This description comes directly from the study's public registry record.
Henry Völzke · 0049 3834 86 75 41 · euthyroid2@uni-greifswald.de
Always discuss trial participation with your own doctor first.
| Bangladesh University of Health | Dhaka, Bangladesh | Not Yet Recruiting |
| Institute of Marine Research | Bergen, Bergen, Norway | Recruiting |
| Islamia College Peshawar | Peshawar, Khyber Pakhtunkhwa, Pakistan | Not Yet Recruiting |
| Jagiellonian University | Krakow, Poland | Not Yet Recruiting |
| The Queen's University of Belfast | Belfast, United Kingdom | Not Yet Recruiting |
| University of Surrey | Guildford, United Kingdom | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06769009